Novo Nordisk: Shares plunge 17% after forecast downgrade – “Most Favored Nation” rule burdens outlook for 2026!

Novo Nordisk shares experienced a massive decline of 17% on the Copenhagen stock exchange early Wednesday morning, effectively neutralizing all gains made this year. The catalyst for this drastic market movement was the forecast for the fiscal year 2026 published on Tuesday evening, which is significantly below market expectations. The Danish pharmaceutical company unexpectedly announced that both revenue and operating profit would decline by 5% to 13% in the coming year. CEO Mike Doustdar confirmed the negative trend and warned investors: "People...